K173887

Substantially Equivalent

cobas CT/NG for use on cobas 6800/8800 systems

Applicant: Roche Molecular Systems, Inc.
Product code: LSL
Advisory panel: Microbiology
Date received: 2017-12-21
Decision date: 2018-03-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Pleasanton, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.